for their interest and support of our study (1) . In particular, we appreciate the emphasis these authors placed on the clinical importance of herpesvirus infection in the context of chromosomal instability syndromes. We are especially grateful for the clinical data the authors shared that support the concept of poorly controlled herpesvirus infection in ataxia-telangiectasia (A-T) and Neijmegen breakage syndrome (NBS) patients (see Table 1 in reference 1).
We agree that exacerbated herpesvirus infections can facilitate the diagnosis of chromosomal instability syndromes and contribute to disease observed in this patient population, most notably, cancer. Along with clinical data, the use of animal models is critical in order to understand the mechanism of disease associated with chromosomal instability syndromes. We would like to draw attention to the fact that several mouse models of human chromosomal instability syndromes (ataxia-telangiectasia-like disorder [ATLD] [2] , NBS [3] , and Fanconi anemia [4] ) are disease free or do not recapitulate all aspects of clinical disease seen in humans with a similar genetic lesion. While many factors could account for such differences, we would like to propose that chronic infection with viral pathogens, absent in most research animal colonies, is likely to further interact with genetic changes to influence disease development. While our study focused on defining the response of an ataxia-telangiectasia-mutated kinase (ATM)-deficient host to gammaherpesvirus infection, other families of vi-ruses that establish chronic infection could further modify host immune responses and disease in A-T patients. Thus, pathogenesis studies that rely on animal models of chromosomal instability syndromes would greatly benefit from combining genetic and physiologically relevant environmental factors, including chronic infections with ubiquitous viral pathogens.
